Abstract
Dr. Reddy’s Ltd. has become a global player within the American, Asian and European pharmaceutical markets over the last 30 years, having started as a small pharmaceutical ingredients supplier in 1984. This success was due to three key factors: a strong corporate governance, long term thinking and innovativeness, and control of the entire value chain. The advantage gained through R&D will be the main driving factor for the company to increase its market share within the next few years and to develop new long-term strategies. Company acquisitions and local production in key markets such as Europe, Russia, and emerging markets enhance the supply chain by being continuously able to strengthen and expand to new pharmaceutical markets in a growing number of countries. Good relations with governments, the willingness and understanding to open up foreign manufacturing plants, and not only importing products but strengthening different countries’ economies, make Dr. Reddy’s a reputable company which will show much more of its potential within the next years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dr. Reddy’s. (2013a). Dr. Reddy’s FY2012 and FY2013 Investors/Financials. Retrieved March 28, 2014, from http://www.drreddys.com/investors/financials.html.
Dr. Reddy’s. (2013b). About us, our founder. Retrieved February 2, 2014, from http://www.drreddys.com/aboutus/our-founder.html.
Dr. Reddy’s History. (2013). Our Journey since 1984. Retrieved February 2, 2014, http://www.drreddys.com/25yearsofhealth/milestones_growing_2009.shtml.
Dr. Reddy’s Management. (2013a). About us, board and management. Retrieved February 2, 2014, from http://www.drreddys.com/aboutus/board-of-directors.html.
Drreddys. (2013). Dr. Reddy’s memory book. Retrieved February 2, 2014, from http://digital.drreddys.com/memorybook/Index.aspx.cited.
Economic Times. (2013). Dr Reddy's Laboratories acquires 93 % shares of OctoPlus. Retrieved March 28, 2014, from http://articles.economictimes.indiatimes.com/2013-02-12/news/37058880_1_octoplus-nv-drl-g-v-prasad.
Economic Times. (2014). Dr Reddy's Laboratories expects 8–10 pc growth in India generics business this fiscal. Retrieved March 30, 2014, fromhttp://articles.economictimes.indiatimes.com/2014-01-10/news/46066424_1_dr-reddy-laboratories-new-drug-pricing-policy.
Healthcare Case. (2014). Dr. Reddy’s Stays Ready with flexible supply chain. Retrieved March 28, 2014, from http://www.ups.com/content/us/en/bussol/browse/industries/healthcare/dr-reddys-laboratories.html.
Hoovers. (2014). Pharma industry. Retrieved March 28, 2014, from http://www.hoovers.com/company-information/cs/company-profile.Sun_Pharmaceutical_Industries_Limited.13a9963460c7243f.html.
Livemint. (2014). Dr. Reddy’s Laboratories expects 8–10 pc growth in India generics business this fiscal. Retrieved from http://www.livemint.com/Money/NnVqbxIch6N9Zcfhcd1WQP/Dr-Reddys-US-business-drives-growth.html.
Mahalingam. (2013). Business Outlook, ‘Inside Dr. Reddy’s’. Retrieved March 27, 2014, from http://business.outlookindia.com/article_v3.aspx?artid=287250.
Ponomarevar. (2011). Russia and India Report. ‘Dr. Reddy’s considers factory acquisition. Retrieved March 26, 2014, from http://in.rbth.com/articles/2011/09/21/dr_reddys_considers_factory_acquisition_13027.html.
Somasekhar. (2012). Dr Reddy’s to buy Dutch firm OctoPlus. Retrieved October 22, 2012, from http://www.thehindubusinessline.com/companies/dr-reddys-to-buy-dutch-firm-octoplus/article4021502.ece.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Egender, M., Rotari, I. (2016). Dr. Reddy’s: A Case Study on Conquering the World with Affordable Medicine for the Masses. In: Segers, R. (eds) Multinational Management. Springer, Cham. https://doi.org/10.1007/978-3-319-23012-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-23012-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23011-5
Online ISBN: 978-3-319-23012-2
eBook Packages: Business and ManagementBusiness and Management (R0)